Question 1

What is the catalog number for 3- (3- (trifluoromethyl) -3H-diazirin-3-yl) aniline?

Accepted Answer

The catalog number for 3- (3- (trifluoromethyl) -3H-diazirin-3-yl) aniline is JH917404.

Question 2

What sizes are available for 3- (3- (trifluoromethyl) -3H-diazirin-3-yl) aniline?

Accepted Answer

3- (3- (trifluoromethyl) -3H-diazirin-3-yl) aniline is available in the following size(s): 1 Each.

Question 3

Is 3- (3- (trifluoromethyl) -3H-diazirin-3-yl) aniline in stock?

Accepted Answer

3- (3- (trifluoromethyl) -3H-diazirin-3-yl) aniline is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 5

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 6

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

3- (3- (trifluoromethyl) -3H-diazirin-3-yl) aniline

Product Specifications

CAS Number

HS Code

Molecular Formula

Molecular Weight

Density

Frequently Asked Questions

Explore Other Products

Thymidylate Synthase (TS106), CF488A conjugate, 0.1mg/mL

Thyroglobulin (Thyroidal Cell Marker) (rTGB24), 0.2mg/mL

Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/1935), CF594 conjugate, 0.1mg/mL

MART-1 / Melan-A (MLANA/788), CF640R conjugate, 0.1mg/mL

Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker) (KRT19/1959R), CF740 conjugate, 0.1mg/mL

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF647 conjugate, 0.1mg/mL